Reviva Pharmaceuticals
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
EBITDA | -4,005 | -6,040 | -6,416 | |
EBIT | -8,035 | -12,113 | -12,954 | -6,284 |
Net Income | -4,010 | -6,053 | -6,432 | -6,259 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -5,589 | -5,012 | -8,194 | -9,100 |
Cash | 13,183 | 10,363 | 5,289 | 13,476 |
Basic Shares | 72,685 | 49,847 | 48,644 | 46,579 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
EBITDA | -29,880 | -39,210 | -24,111 | -8,518 |
EBIT | -60,679 | -78,713 | -24,306 | -10,104 |
Net Income | -29,918 | -39,260 | -24,339 | -8,521 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -33,543 | -28,324 | -18,960 | -10,668 |
Cash | 13,476 | 23,367 | 18,519 | 29,687 |
Basic Shares | 33,147 | 23,798 | 19,516 | 14,790 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-12-31 | $0 |
2025-09-30 | -$0.06 |
2025-06-30 | -$0.12 |
2025-03-31 | -$0.14 |
